Ceftiofur

Ceftiofur

Identifiers
IUPAC name (6R,7R)-7-[ [(2Z)-2-(2-Amino-1,3-thiazol-4-yl)- 2-methoxyiminoacetyl]amino]-3-(furan-2- carbonylsulfanylmethyl)-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	80370-57-6
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H17N5O7S3
Molar mass	523.56 g/mol

WikiDoc Resources for Ceftiofur
Articles
Most recent articles on Ceftiofur Most cited articles on Ceftiofur Review articles on Ceftiofur Articles on Ceftiofur in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ceftiofur Images of Ceftiofur Photos of Ceftiofur Podcasts & MP3s on Ceftiofur Videos on Ceftiofur
Evidence Based Medicine
Cochrane Collaboration on Ceftiofur Bandolier on Ceftiofur TRIP on Ceftiofur
Clinical Trials
Ongoing Trials on Ceftiofur at Clinical Trials.gov Trial results on Ceftiofur Clinical Trials on Ceftiofur at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ceftiofur NICE Guidance on Ceftiofur NHS PRODIGY Guidance FDA on Ceftiofur CDC on Ceftiofur
Books
Books on Ceftiofur
News
Ceftiofur in the news Be alerted to news on Ceftiofur News trends on Ceftiofur
Commentary
Blogs on Ceftiofur
Definitions
Definitions of Ceftiofur
Patient Resources / Community
Patient resources on Ceftiofur Discussion groups on Ceftiofur Patient Handouts on Ceftiofur Directions to Hospitals Treating Ceftiofur Risk calculators and risk factors for Ceftiofur
Healthcare Provider Resources
Symptoms of Ceftiofur Causes & Risk Factors for Ceftiofur Diagnostic studies for Ceftiofur Treatment of Ceftiofur
Continuing Medical Education (CME)
CME Programs on Ceftiofur
International
Ceftiofur en Espanol Ceftiofur en Francais
Business
Ceftiofur in the Marketplace Patents on Ceftiofur
Experimental / Informatics
List of terms related to Ceftiofur

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Ceftiofur is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987. It is marketed by pharmaceutical company Pfizer as Excede.

It is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported.

External links

• Official website